65,437 trials
Aplastic Anemia
Primary: Number of Patients With Engraftment Response — 9 Participants
Bacterial Conjunctivitis
Primary: Participants Who Achieved Clinical Resolution — 82; 74 Participants
Glaucoma · Ocular Hypertension
Primary: Change From Baseline in Mean Peak Macroscopic Conjunctival Hyperemia at Month 1 — 0.32; 0.30; 0.18; 0.02 Number on a scale (score)
Attention Deficit Hyperactivity Disorder
Primary: Maximum Observed Plasma Concentration (Cmax) — 456; 483 nanogram per millileter (ng/mL)
Influenza
Primary: Geometric Mean Titers (GMTs) of Vaccine Antibodies Before and After Vaccination With Either Fluzone® High-Dose or Fluzone® Vaccine. — 40.5; 28.8; 36.4; 41.4 1/dilution…
Diabetes Mellitus, Type 2
Primary: HbA1c Change From Baseline at Week 18 (Interim Analysis) — 0.14; -0.44 percent — p=<0.0001
Seizures
Primary: Length of Seizure After Study Medication Administration — 3.0; 4.3 Minutes
Crohn's Disease
Primary: Mean Interval Between Infliximab Infusions Within the Observation Period (Maintenance Therapy) — 16.89; 34.74; 63.22; 62.86 Days
Healthy Volunteer
Primary: Maximum Observed Plasma Concentration (Cmax) — 109.400 ng/mL
Postmenopausal Women With Osteoporosis
Primary: Mean Percent Change in Lumbar Spine Bone Mineral Density (BMD) From Core Study Baseline, Month 6, Intention to Treat (ITT) Population — 6.2217; 12.7784 Percent Change
Clostridium Infections · Diarrhea
Primary: Cure Rate at End of Therapy — 85.7; 88.2 Percentage of Participants
Attention-Deficit/Hyperactivity Disorder
Primary: Change From Baseline in Attention-Deficit/Hyperactivity Disorder-Rating Scale-IV (ADHD-RS-IV) Total Score at Week 8 - Last Observation Carried Forward (LOCF) — -10.6…
Juvenile Idiopathic Arthritis
Primary: Part I: Percentage of Participants With ≥30% Improvement in Juvenile Idiopathic Arthritis (JIA) American College of Rheumatology (ACR) Core Set and Absence of Fever…
Glioma
Primary: Progression-free Survival
Kidney Failure, Chronic · Growth Hormone Deficiency
Primary: The Change in Amount of Insulin Like Growth Factor (IGF-I) Generated (Day 8-day 1) — 115; 129 mcg/L